BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17151828)

  • 1. The transcriptional activity of HERV-I LTR is negatively regulated by its cis-elements and wild type p53 tumor suppressor protein.
    Chang NT; Yang WK; Huang HC; Yeh KW; Wu CW
    J Biomed Sci; 2007 Mar; 14(2):211-22. PubMed ID: 17151828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional activity of HERV-K-T47D-related long terminal repeats.
    Baust C; Seifarth W; Schön U; Hehlmann R; Leib-Mösch C
    Virology; 2001 May; 283(2):262-72. PubMed ID: 11336551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HERV-K-T47D-Related long terminal repeats mediate polyadenylation of cellular transcripts.
    Baust C; Seifarth W; Germaier H; Hehlmann R; Leib-Mösch C
    Genomics; 2000 May; 66(1):98-103. PubMed ID: 10843810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats.
    Schön U; Seifarth W; Baust C; Hohenadl C; Erfle V; Leib-Mösch C
    Virology; 2001 Jan; 279(1):280-91. PubMed ID: 11145909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional control of the HERV-H LTR element of the GSDML gene in human tissues and cancer cells.
    Sin HS; Huh JW; Kim DS; Kang DW; Min DS; Kim TH; Ha HS; Kim HH; Lee SY; Kim HS
    Arch Virol; 2006 Oct; 151(10):1985-94. PubMed ID: 16625320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional human endogenous retroviral LTR transcription start sites are located between the R and U5 regions.
    Kovalskaya E; Buzdin A; Gogvadze E; Vinogradova T; Sverdlov E
    Virology; 2006 Mar; 346(2):373-8. PubMed ID: 16337666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of GSDML gene by antisense-oriented HERV-H LTR element.
    Huh JW; Kim DS; Kang DW; Ha HS; Ahn K; Noh YN; Min DS; Chang KT; Kim HS
    Arch Virol; 2008; 153(6):1201-5. PubMed ID: 18478180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enhancer activity of solitary long terminal repeat of the human endogenous retrovirus of the HERV-K family].
    Domanskiĭ AN; Akopov SB; Lebedev IuB; Nikolaev LG; Sverdlov ED
    Bioorg Khim; 2002; 28(4):341-5. PubMed ID: 12197391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
    Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
    Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. At least 50% of human-specific HERV-K (HML-2) long terminal repeats serve in vivo as active promoters for host nonrepetitive DNA transcription.
    Buzdin A; Kovalskaya-Alexandrova E; Gogvadze E; Sverdlov E
    J Virol; 2006 Nov; 80(21):10752-62. PubMed ID: 17041225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long terminal repeat of the human endogenous retrovirus ERV-9 is located in the 5' boundary area of the human beta-globin locus control region.
    Long Q; Bengra C; Li C; Kutlar F; Tuan D
    Genomics; 1998 Dec; 54(3):542-55. PubMed ID: 9878258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2).
    Lavie L; Kitova M; Maldener E; Meese E; Mayer J
    J Virol; 2005 Jan; 79(2):876-83. PubMed ID: 15613316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solitary human endogenous retroviruses-K LTRs retain transcriptional activity in vivo, the mode of which is different in different cell types.
    Vinogradova TV; Leppik LP; Nikolaev LG; Akopov SB; Kleiman AM; Senyuta NB; Sverdlov ED
    Virology; 2001 Nov; 290(1):83-90. PubMed ID: 11883008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue specificity of enhancer and promoter activities of a HERV-K(HML-2) LTR.
    Ruda VM; Akopov SB; Trubetskoy DO; Manuylov NL; Vetchinova AS; Zavalova LL; Nikolaev LG; Sverdlov ED
    Virus Res; 2004 Aug; 104(1):11-6. PubMed ID: 15177887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retroviral promoter and a cellular enhancer define a bipartite element which controls env ERVWE1 placental expression.
    Prudhomme S; Oriol G; Mallet F
    J Virol; 2004 Nov; 78(22):12157-68. PubMed ID: 15507602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pCLPG: a p53-driven retroviral system.
    Strauss BE; Costanzi-Strauss E
    Virology; 2004 Apr; 321(2):165-72. PubMed ID: 15051377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional analysis of the HERV-K LTR residing in the KIAA1245/NBPF subfamily].
    Abrarova ND; Stukacheva EA; Pleshkan VV; Vinogradova TV; Sverdlov ED
    Mol Biol (Mosk); 2010; 44(4):627-34. PubMed ID: 20873221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoters through the epithelial specific enhancer.
    Desaintes C; Hallez S; Detremmerie O; Burny A
    Oncogene; 1995 Jun; 10(11):2155-61. PubMed ID: 7784059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 transactivation through various p53-responsive elements.
    Park DJ; Chumakov AM; Miller CW; Pham EY; Koeffler HP
    Mol Carcinog; 1996 Jun; 16(2):101-8. PubMed ID: 8645424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter activity of the long terminal repeats of porcine endogenous retroviruses of the Korean domestic pig.
    Ha HS; Huh JW; Kim DS; Kang DW; Cho BW; Kim HS
    Mol Cells; 2007 Aug; 24(1):148-51. PubMed ID: 17846510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.